GLYCEMIC STATUS IN COVID AND POST COVID-19 INFECTION IN HOSPITALISED PATIENTS.

Abstract

Background: Coronavirus disease 2019 (COVID-19) caused by coronavirus 2 (SARS CoV-2) has a wide spectrum of clinical picture which consist asymptomatic infection to severe respiratory symptoms. The hyperglycemia that occurs in the acute inammatory state of COVID-19 patients is found to be more pronounced amongst diabetes, prediabetes, and/or with obesity. Present study is undertaken with the objectives to analyse Glycemic Status and dysglycemic grounds in COVID-19 hospitalized patients. Material & Methods: This Cross sectional Observational study was conducted in Department of Medicine, MGM Medical College and Hospital, Aurangabad [Maharashtra], India. 75 RT-PCR conrmed Covid-19 patients for dysglycemic status were enrolled. The Observations & Results: mean age of patients in the study was 55.04±16.83 years. The male had (60.0%) predominance than female (40.0%). All the patients were given steroids during treatment at hospitalisation, 72(96.0%) patients were provided Remdesivir, 66(88.0%) were treated with anticoagulants and 25(33.3%) of patients were given fabiu. The mean HbA1C level at ICU admission was 7.16±0.84, while the mean HbA1C level 3 months post hospitalization irrespective of discharge date was 7.96±1.30. This observation was statistically signicant. Present study conrmed Conclusion: that the blood glucose levels signicantly found increased not only during covid-19 hospitalization but also after laps of 3 months of COVID infection. Also noted signicantly higher values of HBA1c at three months post infections on discharge.